Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease-Reference-Cited by-同舟云学术

Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease

Published:2024-01 Issue:1 Volume:105 Page:200-208
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Bhandari Sunil^ORCID,Mehta Samir,Khawaja Arif^ORCID,Cleland John G.F.,Ives Natalie,Cockwell Paul

Funder

Medical Research Council

National Institute for Health and Care Research

Publisher

Elsevier BV

Subject

Nephrology

Reference23 articles.

1. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomised clinical trials;Xie;Am J Kidney Dis,2016

2. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD;Taler;Am J Kidney Dis,2013

3. Renin–angiotensin system inhibition in advanced chronic kidney disease;Bhandari;N Engl J Med,2022

4. Angiotensin receptors and their antagonist;Goodfriend;N Engl J Med,1996

5. Diabetics Exposed to Telmisartan and Enalapril Study Group. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy;Barnett;N Engl J Med,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of ACEI/ARB therapy with total and cardiovascular death in coronary artery disease patients with advanced chronic kidney disease: a large multi-center longitudinal study;Renal Failure;2024-09-04

2. Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes;Kidney International Reports;2024-08